Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.
NCT ID: NCT00336687
Last Updated: 2010-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
322 participants
OBSERVATIONAL
2005-07-31
2006-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in Reanimation
NCT03979625
A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients
NCT00198575
Trauma Associated Bleeding: Effectiveness of an Early Coagulation Support Protocol
NCT03354559
Incidence of Trauma Induced Coagulopathy in Patients With Prehospital Administration of Fibrinogen
NCT03572309
Platelet Transfusion in Critically Ill Patients With Thrombocytopenia
NCT06599385
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Contraindication of myelogram
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Moulins Hospital
OTHER
Centre Hospitalier Universitaire de Saint Etienne
OTHER
LA ROCHE SUR YON HOSPITAL
UNKNOWN
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
CHU Clermont-Ferrand
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fabrice Thiolliere, Dr
Role: STUDY_DIRECTOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clermont-Ferrand University Hospital
Clermont-Ferrand, Auvergne, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHU63-0013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.